Antiphospholipid syndrome accompanied by a silent splenic infarct in a patient with juvenile SLE [2]

Rheumatology International

Volumn 26, Issue 10, 2006, Pages 951-952

  Constantin, Tamás ^a   Ponyi, Andrea ^a,b   Varga, Edit ^a   Dankó, Katalin ^b   Fekete, György ^a   Kovács, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CREATININE; DNA ANTIBODY; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; NITROGEN; PROCALCITONIN; UREA; WARFARIN;

ANEMIA; ANTIPHOSPHOLIPID SYNDROME; BLOOD CELL COUNT; BONE MARROW BIOPSY; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; CORTICOSTEROID THERAPY; CYTOPENIA; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; FETUS WASTAGE; FEVER; HEP 2 CELL; HISTOPATHOLOGY; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION TEST; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SPLEEN INFARCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CHILD; COUMARINS; FEMALE; GLYCOPROTEINS; HEPARIN; HUMANS; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; REFERENCE VALUES; SPLENIC INFARCTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33745509804     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0125-4     Document Type: Letter

References (14)

1. Arkachaisri T, Lehman TJA (1999) Systemic lupus erythematosus and related disorders of childhood. Curr Opin Rheum 11:384-395
2. Avcin T, Cimaz R, Meroni P (2002) Recent advances in antiphospholipid antibodies and antiphospholipid syndrome in pediatric populations. Lupus 11:4-10
3. Berube C, Mitchel L, Silverman E et al (1998) The realtionship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 44:351-356
4. Bruce IN, Clark-Solonika CA, Spitzer KA et al (2000) Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. J Rheumatol 27:2833-2837
5. Kim JH, Ha HK, Yoon KH et al (1999) CT features of abdominal manifestation of primary antiphospholipid syndrome. J Comput Assist Tomogr 23:678-683
6. Lee T, von Schieven E, Sandborg C (2001) Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol 13:415-421
7. Male C, Lechner K, Eichinger S et al (1999) Clinical significance of lupus anticoagulants in children. J Pediatr 134:199-205
8. Pierangeli SS, Ghavari AE, Harris EN (2001) Testing for antiphospholipid antibodies: problems and solutions. Clin Obstet Gynecol 44:48-57
9. Rand JH (2002) Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 90:29-37
10. Roubey RAS (2000) Antiphospholipid syndrome: antibodies and antigens. Curr Opin Hematol 7:316-320
11. Roubey RAS (2002) Treatment of antiphospholipid syndrome. Curr Opin Rheum 14:238-242
12. von Scheven E, Glidden DV, Elder ME (2002) Anti-β2-glycoprotein I antibodies in pediatric sytemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 47:414-420
13. Siemens HJG, Gutsche S, Brückner S et al (2000) Antiphospholipid antibodies in children without and in adults with and without thrombophilia. Thromb Res 98:241-247
14. Wilson WA, Ghavari AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for defintie antiphospholipid syndrome. Arthritis Rheum 42:1309-1311